Top

Journal of Cancer Survivorship

Published in:

01-03-2007

Melanoma survivorship: research opportunities

Authors: Susan A. Oliveria, Jennifer L. Hay, Alan C. Geller, Maureen K. Heneghan, Mary S. McCabe, Allan C. Halpern

Published in: Journal of Cancer Survivorship | Issue 1/2007

Abstract

Introduction

The rising incidence and mortality rates of melanoma, the most fatal form of skin cancer, are among the greatest increases of all preventable cancers over the past decade. However, because of recent advances in early detection, secondary prevention efforts, and treatment, the number of melanoma survivors is increasing. Little research has been conducted on melanoma survivors and important opportunities exist for research in this understudied population. Here, we outline the important research opportunities related to the study of melanoma survivorship and summarize the paucity of literature currently available.

Materials and methods

A computerized literature search was performed of the MEDLINE® database of the National Library of Medicine from 1966–2005. The scope of the search was limited to those studies published in English. The search was conducted using the following MeSH headings: melanoma, neoplasms, skin neoplasms, survival, and survival rate. The reference lists of relevant book chapters and review articles were further reviewed, and printed materials from recent scientific meetings addressing this topic were obtained.

Results

Several factors that affect melanoma survivors warrant further study, including: physiologic long-term effects; psychosocial, behavioral, and cognitive factors; demographic characteristics; surveillance practices; recurrences, secondary primaries, and other cancers; family members of survivors; and economic issues, access to health care/life insurance.

Conclusions

Understanding recurrence and second primary cancer risk, psychosocial and cognitive characteristics, behaviors, surveillance patterns, economic sequelae, and family issues of melanoma survivors is important from a public health standpoint to promote the health and well-being of this cohort.

Implications for cancer survivors

Melanoma is an understudied cancer, and the incidence and mortality of this disease are increasing. Describing the long term burden of this cancer and identifying factors that contribute to them will facilitate efforts to develop responsive secondary prevention strategies.

Aitchison, T. C., Sirel, J. M., Watt, D. C., & MacKie, R. M. (1995). Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group. British Medical Journal, 311(7019), 1536–1539; discussion 1539–1541.PubMed

Aitken, J. F., Green, A. C., MacLennan, R., Youl, P., & Martin, N. G. (1996). The Queensland Familial Melanoma Project: Study design and characteristics of participants. Melanoma Research, 6(2), 155–165.PubMed

American Cancer Society (2005). American cancer society: Cancer facts & figures 2005. Atlanta, GA: American Cancer Society.

Armstrong, B. K., & Kricker, A. (1993). How much melanoma is caused by sun exposure? Melanoma Research, 3(6), 395–401.PubMed

Autier, P., & Dore. J. F. (1998). Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. International Journal of Cancer, 77(4), 533–537.

Aziz, N. M. (2002). Cancer survivorship research: Challenge and opportunity. Journal of Nutrition, 132(11 Suppl), 3494S–3503S.PubMed

Azzarello, L. M., Dessureault, S., & Jacobsen, P. B. (2006). Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiology Biomarkers & Prevention, 15(1), 142–145.

Berndt. E., & Crown, W. (2002). Labor force activity in cancer patients with anemia. Quality of Life in Oncology 5, 10–13.

Berwick, M., Armstrong, B. K., Ben-Porat, L., Fine, J., Kricker, A., Eberle, C., et al. (2005). Sun exposure and mortality from melanoma. Journal of the National Cancer Institute, 97(3), 195–199.PubMedCrossRef

10.

Berwick, M., Begg, C. B., Fine, J. A., Roush, G. C., & Barnhill, R. L. (1996). Screening for cutaneous melanoma by skin self-examination. Journal of the National Cancer Institute, 88(1), 17–23.PubMed

11.

Boyle, D. A. (2003). Psychological adjustment to the melanoma experience. Seminars in Oncology Nursing, 19(1), 70–77.PubMed

12.

Breslow, A. (1970). Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery, 172(5), 902–908.PubMed

13.

Brown, J. E., King, M. T., Butow, P. N., Dunn, S. M., & Coates, A. S. (2000). Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: An application of multilevel models. Quality of Life Research, 9(1), 75–85.PubMed

14.

Brown, M. L., Riley, G. F., Schussler, N., & Etzioni, R. D. Health care costs related to cancer treatment from SEER-Medicare data. Medical Care, 40(Suppl 8), 104–117.

15.

Butow, P. N., Coates, A. S., & Dunn, S. M. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology, 17(7), 2256–2263.PubMed

16.

Cancer survivorship—United States, 1971–2001. (2004). Morbidity and Mortality Weekly Report, 53(24), 526–529.

17.

Carmel, S., Shani, E., & Rosenberg, L. (1994). The role of age and an expanded Health Belief Model in predicting skin cancer protective behavior. Health Education Research, 9(4), 433–447.PubMed

18.

Carmichael, V. E., & Wilson, K. S. (1992). Primary cutaneous malignant melanoma: Experience of the British Columbia Cancer Agency from 1972 to 1981. Canadian Journal of Surgery, 35(6), 589–597.

19.

Chang, S., Longm, S. R., Kutikova, L., Bowman, L., Finley, D., Crown, W. H., et al. (2004). Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. Journal of Clinical Oncology, 22(17), 3524–3530.PubMed

20.

Cohn-Cedermark, G., Mansson-Brahme, E., Rutqvist, L. E., Larsson, O., Singnomklao, T., & Ringborg, U. (1999). Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncoloâgica, 38(5), 549–557.

21.

Coups, E. J, & Ostroff, J. S. (2005). A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Preventive Medicine, 40(6), 702–711.PubMed

22.

Cristofolini, M., Zumiani, G., Boi, S., & Piscioli, F. (1986). Community detection of early melanoma. Lancet, 1(8473), 156.PubMed

23.

Demark-Wahnefried, W., Aziz, N. M., Rowland, J. H., & Pinto, B. M. (2005). Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. Journal of Clinical Oncology, 23(24), 5814–5830.PubMed

24.

Dennis, L. K., White, E., & Lee, J. A. (1993). Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes & Control, 4(2), 93–100.

25.

Dicker, T. J., Kavanagh, G. M., Herd, R. M., Ahmad, T., McLaren, K. M., Chetty, U., et al. (1999). A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. British Journal of Dermatology, 140(2), 249–254.PubMed

26.

Diepgen, T. L., & Mahler, V. (2002). The epidemiology of skin cancer. British Journal of Dermatology, 146(Suppl 61), 1–6.PubMed

27.

DiFronzo, L. A., Wanek, L. A., Elashoff, R., & Morton, D. L. (1999). Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Annals of Surgical Oncology, 6(7), 705–711.PubMed

28.

Duggleby, W. F., Stoll, H., Priore, R. L., Greenwald, P., & Graham, S. (1981). A genetic analysis of melanoma-polygenic inheritance as a threshold trait. American Journal of Epidemiology, 114(1), 63–72.PubMed

29.

Edman, R. L., & Klaus, S. N. (2000). Is routine screening for melanoma a benign practice? Journal of the American Medical Association, 284(7), 883–886.PubMed

30.

English, D. R., Milne, E., & Simpson, J. A. (2006). Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia). Cancer Causes & Control, 17(1), 103–107.

31.

Fawzy, F. I., Fawzy, N. W., Hyun, C. S., Elashoff, R., Guthrie, D., Fahey, J. L., et al. (1993). Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Archives of General Psychiatry, 50(9), 681–689.PubMed

32.

Fillenbaum, G. G., Pieper, C. F., Cohen, H. J., Cornoni-Huntley, J. C., & Guralnik, J. M. (2000). Comorbidity of five chronic health conditions in elderly community residents: Determinants and impact on mortality. Journal of Gerontology: Medical Sciences, 55A, M84–M89.

33.

Fireman, B. H., Quesenberry, C. P., Somkin, C. P., Jacobson, A. S., Baer, D., West, D., et al. (1997). Cost of care for cancer in a health maintenance organization. Health Care Financing Review, 18(4), 51–76.PubMed

34.

Freiman, A., Yu, J., Loutfi, A., & Wang, B. (2004). Impact of melanoma diagnosis on sun-awareness and protection: Efficacy of education campaigns in a high-risk population. Journal of Cutaneous Medicine and Surgery, 8(5), 303–309.PubMed

35.

Friedman, R. J., Rigel, D. S., Silverman, M. K., Kopf, A. W., & Vossaert, K. A. (1991). Malignant melanoma in the 1990s: The continued importance of early detection and the role of physician examination and self-examination of the skin. CA-A Cancer Journal for Clinicians, 41(4), 201–226.PubMed

36.

Friedman, L. C., Webb, J. A., Bruce, S., Weinberg, A. D., & Cooper, H. P. (1995). Skin cancer prevention and early detection intentions and behavior. American Journal of Preventive Medicine, 11(1), 59–65.PubMed

37.

Garbe, C. (2002). A rational approach to the follow-up of melanoma patients. Recent Results in Cancer Research, 160, 205–215.PubMed

38.

Garbe, C., & Orfanos, C. E. (1992). Epidemiology of malignant melanoma in central Europe: Risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Research, (Suppl 2), 285–294.

39.

Garman, K. S., Pieper, C. F., Seo, P., & Cohen, H. J. (2003). Function in elderly cancer survivors depends on comorbidities. Journal of Gerontology, 58A(11), 119–1124.

40.

Geller, A. C., Emmons, K. M., Brooks, D. R., Powers, C, Zhang, Z., Koh, H. K., et al. (2006). A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer, 107(4), 806–814.PubMed

41.

Geller, A. C., Koh, H. K., Miller, D. R., & Lew, R. A. (1992). Practices and beliefs concerning screening family members of patients with melanoma. Results of a survey of New England dermatologists. Journal of the American Academy of Dermatology, 26(3 Pt 2), 419–422.PubMed

42.

Geller, A. C., Miller, D. R., Annas, G. D., Demierre, M. F., Gilchrest, B. A., & Koh, H. K. (2002). Melanoma incidence and mortality among US whites, 1969–1999. Journal of the American Medical Association, 288(14), 1719–1720.PubMed

43.

Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999). The pathogenesis of melanoma induced by ultraviolet radiation. New England Journal of Medicine, 340(17), 1341–1348.PubMed

44.

Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003). Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist, 8(6), 541–552.PubMed

45.

Goggins, W. B., Finkelstein, D. M., & Tsao, H. (2001). Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer, 91(4), 874–880.PubMed

46.

Goldsmith, L. A., Koh, H. K., Bewerse, B. A., Reilley, B., Wyatt, S. W., Bergfeld, W. F., et al. (1996). Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. In American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, D.C., April 8–10, 1995. Journal of the American Academy of Dermatology, 35(5 Pt 1), 748–756.PubMed

47.

Gotay, C. C., & Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancers. Journal of the National Cancer Institute, 90(9), 656–667.PubMed

48.

Greer, S., Morris, T., Pettingale, K. W., & Haybittle, J. L. (1990). Psychological response to breast cancer and 15-year outcome. Lancet, 335(8680), 49–50.PubMed

49.

Hall, H. I., May, D. S., Lew, R. A., Koh, H. K., & Nadel, M. (1997). Sun protection behaviors of the U.S. white population. Preventive Medicine, 26(4), 401–407.PubMed

50.

Hay, J., Ostroff, J., Martin, A., Serle, N., Soma, S., Mujumdar, U., et al. (2005). Skin cancer risk discussions in melanoma-affected families. Journal of Cancer Education, 20(4), 240–246.PubMed

51.

Hewitt, M., Breen, N., & Devesa, S. (1999). Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey. Journal of the National Cancer Institute, 91(17), 1480–1486.PubMed

52.

Hewitt, M., Rowland, J. H., & Yancik, R. (2003). Cancer survivors in the United States: Age, health, and disability. Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 58(1), 82–91.

53.

Hillner, B. E., Kirkwood, J. M., & Agarwala, S. S. (2001). Burden of illness associated with metastatic melanoma: An audit of 100 consecutive referral center cases. Cancer, 91(9), 1814–1821.PubMed

54.

Honda, K., & Neugut, A. I. (2004). Associations between perceived cancer risk and established factors in a national community sample. Cancer Detection and Prevention, 28, 1–7.PubMed

55.

Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., et al. (2001). Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute, 93(11), 824–842.PubMed

56.

Huang, X., Soong, S., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1997). Classification of localized melanoma by the exponential survival trees method. Cancer, 79(6), 1122–1128.PubMed

57.

Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA-A Cancer Journal for Clinicians, 55(1), 10–30.PubMed

58.

Keesling, B., & Friedman, H. S. (1987). Psychosocial factors in sunbathing and sunscreen use. Health Psychology, 6(5), 477–493.PubMed

59.

Khayat, D., Rixe, O., Martin, G., Soubrane, C., Banzet, M., Bazex, J. A., et al. (2003). Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer, 97(8), 1941–1946.PubMed

60.

Koh, H. K. (1991). Cutaneous melanoma. New England Journal of Medicine, 325(3), 171–182.PubMedCrossRef

61.

Koh, H. K., Geller, A. C, & Lew, R. A. (1999). Melanoma. In B. S. Kramer, J. K. Gohagen, & P. C. Prorok (Eds.), Cancer screening: Theory and practice (pp. 379–408). New York: Marcel Dekker.

62.

Koh, H. K., Lew, R. A., & Prout, M. N. (1989). Screening for melanoma/skin cancer: Theoretic and practical considerations. Journal of the American Academy of Dermatology, 20(2 Pt 1), 159–172.PubMed

63.

Koh, H. K., Miller, D. R., Geller, A. C., Clapp, R. W., Mercer, M. B., & Lew, R. A. (1992). Who discovers melanoma? Patterns from a population-based survey. Journal of the American Academy of Dermatology, 26(6), 914–919.PubMed

64.

Kopf, A. W., Rigel, D. S., & Friedman, R. J. (1982). The rising incidence and mortality rate of malignant melanoma. Journal of Dermatologic Surgery and Oncology, 8(9), 760–761.PubMed

65.

Kornblith, A. B. (1998). Psychosocial adaptation of cancer survivors. In J. C. Holland (Ed.), New York: Oxford University Press.

66.

Leman, J. A., & Mac Kie, R. M. (2003). Late (>10 years) recurrence of melanoma: The Scottish experience. British Journal of Dermatology, 148(2), 372–373.PubMed

67.

Leventhal, H., Kelly, K., & Leventhal, E. A. (1999). Population risk, actual risk, perceived risk, and cancer control: A discussion. Journal of the National Cancer Institute. Monographs, 25, 81–85.PubMed

68.

Lipkus, I. M., Rimer, B. K., & Strigo, T. S. (1996). Relationships among objective and subjective risk for breast cancer and mammography stages of change. Cancer Epidemiology Biomarkers and Preventions, 5(12), 1005–1011.

69.

MacKie, R. M., & Hole, D. (1992). Audit of public education campaign to encourage earlier detection of malignant melanoma. British Medical Journal, 304(6833), 1012–1015.PubMed

70.

Manne, S., Fasanella, N., Connors, J., Floyd, B., Wang, H., & Lessin, S. (2004). Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: Prevalence and predictors. Preventive Medicine, 39(1), 36–47.PubMed

71.

Manne, S., & Lessin, S. (2006). Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. Journal of Behavioral Medicine, 29(5), 419–434.PubMed

72.

Margolis, D. J., Halpern, A. C., Rebbeck, T., Schuchter, L., Barnhill, R. L., Fine, J., et al. (1998). Validation of a melanoma prognostic model. Archives of Dermatology, 134(12), 1597–1601.PubMed

73.

Masback, A., Westerdahl, J., Ingvar, C., Olsson, H., & Jonsson, N. (1997). Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations. Cancer, 79(2), 275–283.PubMed

74.

McBride, C. M., Emmons, K. M., & Lipkus, I. M. (2003). Understanding the potential of teachable moments: The case of smoking cessation. Health Education Research, 18(2), 156–170.PubMed

75.

McKenna, D. B., Stockton, D., Brewster, D. H., & Doherty, V. R. (2003). Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: A population-based retrospective cohort study in Scotland. British Journal of Cancer, 88(1), 74–78.PubMed

76.

McPherson, M., Elwood, M., English, D. R., Baade, P. D., Youl, P. H., & Aitken, J. F. (2006). Presentation and detection of invasive melanoma in a high-risk population. Journal of the American Academy of Dermatology, 54(5), 783–792.PubMed

77.

Miller, D. R., Geller, A. C., Wyatt, S. W., Halpern, A., Howell, J. B., Cockerell, C., et al. (1996). Melanoma awareness and self-examination practices: Results of a United States survey. Journal of the American Academy of Dermatology, 34(6), 962–970.PubMed

78.

Miller, D. L., & Weinstock, M. A. (1994). Nonmelanoma skin cancer in the United States: Incidence. Journal of the American Academy of Dermatology, 30(5 Pt 1), 774–778.PubMed

79.

Molassiotis, A., Van Den Akker, O. B., Milligan, D. W., & Goldman, J. M. (1997). Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. Journal of Psychosomatic Research, 42(3), 275–285.PubMed

80.

National Cancer Institute (2002). US estimated complete prevalence counts on 1/1/2002 first malignant cancer only by cancer site, sex, and race. CanQuest Hosting Service, 2002. (Ed.). Available at http://canques.seer.cancer.gov.

81.

NIH Consensus conference (1992). Diagnosis and treatment of early melanoma. Journal of the American Medical Association, 268(10), 1314–1319.

82.

Ostroff, J., Garland, J., Moadel, A., Fleshner, N., Hay, J., Cramer, L., et al. (2000). Cigarette smoking patterns in patients after treatment of bladder cancer. Journal of Cancer Education, 15(2), 86–90.PubMed

83.

Pakilit, A. T., Kahn, B. A., Petersen, L., Abraham, L. S., Greendale, G. A., & Ganz, P. A. (2001). Making effective use of tumor registries for cancer survivorship research. Cancer, 92(5), 1305–1314.PubMed

84.

Pehamberger, H., Binder, M., Knollmayer, S., & Wolff, K. (1993). Immediate effects of a public education campaign on prognostic features of melanoma. Journal of the American Academy of Dermatology, 29(1), 106–109.PubMed

85.

Pinto, B. M., Eakin, E., & Maruyama, N. C. (2000). Health behavior changes after a cancer diagnosis: What do we know and where do we go from here? Annals of Behavioral Medicine, 22(1), 38–52.PubMedCrossRef

86.

Ponder, M., Lee, J., Green, J., & Richards, M. (1996). Family history and perceived vulnerability to some common diseases: A study of young people and their parents. Journal of Medical Genetics, 33(6), 485–492.PubMed

87.

Rhee, J. S., Matthews, B. A., Neuburg, M., Smith, T. L., Burzynski, M., & Nattinger, A. B. (2004). Quality of life and sun-protective behavior in patients with skin cancer. Archives of Otolaryngology, Head & Neck Surgery, 130(2), 141–146.

88.

Rhodes, A. R. (1995). Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer, 75(Suppl 2), 613–636.PubMed

89.

Rhodes, A. R., Weinstock, M. A., Fitzpatrick, T. B., Mihm, M. C., Jr., & Sober, A. J. (1987). Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. Journal of the American Medical Association, 258(21), 3146–3154.PubMed

90.

Robison, L. L. (2004). Cancer survivorship: Unique opportunities for research. Cancer Epidemiology Biomarkers & Preventions, 13(7), 1093.

91.

Robinson, J. K., Rigel, D. S., & Amonette, R. A. (1998). What promotes skin self-examination? Journal of the American Academy of Dermatology, 38(5 Pt 1), 752–757.PubMed

92.

Rogentine, G. N., Jr., van Kammen, D. P., Fox, B. H., Docherty, J. P., Rosenblatt, J. E., Boyd, S. C., et al. (1979). Psychological factors in the prognosis of malignant melanoma: A prospective study. Psychosomatic Medicine, 41(8), 647–655.PubMed

93.

Roush, G. C., McKay, L., & Holford, T. R. (1992). A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer, 69(7), 1714–1720.PubMed

94.

Sahin, S., Rao, B., Kopf, A. W., Lee, E., Rigel, D. S., Nossa, R., et al. (1997). Predicting ten-year survival of patients with primary cutaneous melanoma: Corroboration of a prognostic model. Cancer, 80(8), 1426–1431.PubMed

95.

Salasche, S. J. (2000). Epidemiology of actinic keratoses and squamous cell carcinoma. Journal of the American Academy of Dermatology, 42(1 Pt 2), 4–7.PubMed

96.

Schag, C. A. C., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, S. S. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127–141.PubMed

97.

Schuchter, L., Schultz, D. J., Synnestvedt, M., Trock, B. J., Guerry, D., Elder, D. E., et al. (1996). A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Annals of Internal Medicine, 125(5), 369–375.PubMed

98.

Scotto, J., Pitcher, H., & Lee, J. A. (1991). Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. International Journal of Cancer, 49(4), 490–497.

99.

Senior, V., Marteau, T. M., & Weinman, J. (2000). Impact of genetic testing on causal models of heart disease and arthritis: An analogue study. Psychology Health, 14, 1077–1088.

100.

Sigurdardottir, V., Bolund, C., & Sullivan, M. (1996). Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy. Acta Oncoloâgica, 35(2), 149–158.

101.

Soong, S. J., Harrison, R. A., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1998). Factors affecting survival following local, regional, or distant recurrence from localized melanoma. Journal of Surgical Oncology, 67(4), 228–233.PubMed

102.

Soong, S. J., Shaw, H. M., Balch, C. M., McCarthy, W. H., Urist, M. M., & Lee, J. Y. (1992). Predicting survival and recurrence in localized melanoma: A multivariate approach. World Journal of Surgery, 16(2), 191–195.PubMed

103.

Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2(8668), 888–891.PubMed

104.

Stavraky, K. M., Donner, A. P., Kincade, J. E., & Stewart, M. A. (1988). The effect of psychosocial factors on lung cancer mortality at one year. Journal of Clinical Epidemiology, 41(1), 75–82.PubMed

105.

Surveillance, Epidemiology, and End Results (SEER) Program (2003). SEERStat Database: Incidence—SEER 9 Regulations. Bethesda, Maryland: National Cancer Institute, Division of Cancer Control and Population Sciences. Available at http://www.seer.cancer.gov.

106.

Theobald, T., Marks, R., Hill, D., & Dorevitch, A. (1991). “Goodbye sunshine”: Effects of a television program about melanoma on beliefs, behavior, and melanoma thickness. Journal of the American Academy of Dermatology, 25(4), 717–723.PubMedCrossRef

107.

Trask, P. C., Paterson, A. G., Esper, P., Pau, J., & Redman, B. (2004). Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology, 13(8), 526–536.PubMed

108.

Trask, P. C., Paterson, A. G., Hayasaka, S., Dunn, R. L., Riba, M., & Johnson, T. (2001). Psychosocial characteristics of individuals with non-stage IV melanoma. Journal of Clinical Oncology, 19(11), 2844–2850.PubMed

109.

Tsao, H., Rogers, G. S., & Sober, A. J. (1998). An estimate of the annual direct cost of treating cutaneous melanoma. Journal of the American Academy of Dermatology, 38(5 Pt 1), 669–680.PubMed

110.

Tucker, M. A., Fraser, M. C., Goldstein, A. M., Elder, D. E., Guerry, D. T., & Organic, S. M. (1993). Risk of melanoma and other cancers in melanoma-prone families. Journal of Investigative Dermatology, 100(3), 350S–355S.PubMed

111.

Weinstein, N. D. (1984). Why it won’t happen to me: Perceptions of risk factors and susceptibility. Health Psychology, 3(5), 431–457.PubMed

112.

Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10(5), 481–500.PubMed

113.

Weinstock, M. A. (2000). Early detection of melanoma. Journal of the American Medical Association, 284(7), 886–889.PubMed

Title: Melanoma survivorship: research opportunities
Authors: Susan A. Oliveria
Jennifer L. Hay
Alan C. Geller
Maureen K. Heneghan
Mary S. McCabe
Allan C. Halpern
Publication date: 01-03-2007
Publisher: Kluwer Academic Publishers-Plenum Publishers
Published in: Journal of Cancer Survivorship / Issue 1/2007
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-007-0009-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Materials and methods

Results

Conclusions

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 1/2007

Defining cancer survivorship

Optimizing cancer survivorship

Age and attachment style impact stress and depressive symptoms among caregivers: a prospective investigation

Preparing professional staff to care for cancer survivors

Screening practices in cancer survivors

Long term care planning for cancer survivors: a health services research agenda

Keynote webinar | Spotlight on antibody–drug conjugates in cancer